Infliximab-induced disseminated histoplasmosis in a patient with Crohn's disease

2008 ◽  
Vol 5 (5) ◽  
pp. 283-287 ◽  
Author(s):  
Susan Galandiuk ◽  
Brian R Davis
Author(s):  
Esfandiar Shojaei ◽  
Joanna C Walsh ◽  
Nikhil Sangle ◽  
Brian Yan ◽  
Michael S Silverman ◽  
...  

Abstract Disseminated histoplasmosis is a life-threatening disease usually seen in immunocompromised patients living in endemic areas. We present an apparently immunocompetent patient with gastrointestinal histoplasmosis who was initially diagnosed as biopsy-proven Crohn’s disease. Following discontinuation of anti-inflammatory drugs and institution of antifungal therapy, his GI illness completely improved. Specific fungal staining should be routinely included in histopathologic assessment of tissue specimens diagnosed as Crohn’s disease.


2018 ◽  
Vol 126 (3) ◽  
pp. e119-e120
Author(s):  
Renata De Almeida Zieger ◽  
Marina Girardi Shchueigard ◽  
Andressa Cristina Hashigushi De Almeida ◽  
Luan Santana Nataniel Kovalski ◽  
Manuela Domingues Martins ◽  
...  

2018 ◽  
Vol 37 (5) ◽  
pp. 472-474 ◽  
Author(s):  
Bhavesh Bhut ◽  
Akshay Kulkarni ◽  
Varnika Rai ◽  
Vinita Agrawal ◽  
Abhai Verma ◽  
...  

2019 ◽  
Vol 211 (5) ◽  
pp. 206 ◽  
Author(s):  
Michael B MacIsaac ◽  
Sasha R Fehily ◽  
Stephen Muhi ◽  
Linda Yang ◽  
Penelope A McKelvie ◽  
...  

2001 ◽  
Vol 3 (Supplement 2) ◽  
pp. 58-62
Author(s):  
G. Olaison ◽  
P. Andersson ◽  
P. Myrelid ◽  
K. Smedh ◽  
J. Soderholm ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A68-A68
Author(s):  
G VANASSCHE ◽  
D VANBECKEVOORT ◽  
D BIELEN ◽  
G COREMANS ◽  
I AERDEN ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document